About the company
aiCurePath Health Inc. is a Canada-registered AI health technology company committed to integrating the ancient Chinese medical philosophy of “Preventive Treatment of Disease” with advanced artificial intelligence and innovative business models.
The company has developed North America’s first AI-driven, Traditional Chinese Medicine–centered health management platform APP, guided by the mission: “Empowering TCM with AI, Safeguarding Health through Technology.”
The platform offers an all-in-one ecosystem of intelligent health services, including:
• AI-driven Health Assessment System
• Online Text and Video Consultations
• Offline Appointment Booking for TCM Clinics
• AI-assisted Diagnostic System
• AI-based Lifelong Health Management Framework
• Online and Offline Health Education Programs
• TCM and Wellness Product Marketplace
Powered by AI and rooted in TCM’s holistic principles of balance and prevention, the platform delivers personalized, data-driven health management covering prevention, regulation, and recovery—empowering users to maintain wellness throughout every stage of life.
This pioneering project has been realized through the collaborative support of leading TCM universities in Shanghai, Beijing, Guangzhou, Nanjing, and North America, as well as National TCM Masters and distinguished scholars. It has also received strong technical and financial backing from top Shenzhen software firms, senior AI engineers from leading North American tech companies, and a renowned investment institution in Shanghai.
After five years of meticulous planning, research, and development, Phase I of the platform has been successfully completed, and Phase II—focused on global expansion and system enhancement—is now underway.
On behalf of all co-founders of aiCurePath Health Inc., I extend our heartfelt gratitude to every university, expert, engineer, and partner whose dedication and vision have made this project possible.
Backed BY
Yuhua Li
Yuhua Li is one of the investors of aiCurePath and a partner at a well-known investment firm based in Shanghai, China. She has long been engaged in angel investments in the fields of finance, healthcare, and high technology, and has successfully helped multiple venture enterprises secure venture capital funding in the Chinese and Hong Kong capital markets.
Haiming chen
Haiming Chen is one of the investors and shareholders of aiCurePath, serving as the company’s Vice Chairman and CFO. He is fully responsible for the company’s financial management and capital operations. Mr. Chen is also the Chairman of Shanghai Chenting Investment Co., Ltd., and was among the first group of distinguished entrepreneurs during the early stages of China’s economic reform and opening-up. As one of the founding initiators and original shareholders of Shanghai Bank, he has long been engaged in investments in real estate development, banking, insurance, and medical technology, achieving remarkable success and recognition in both the Chinese and Hong Kong capital markets.